Claims
- 1. A curable epoxy resin composition for encapsulation of a solid state device, which comprises: (A) at least one cycloaliphatic epoxy resin, (B) a curing agent comprising hexahydro-4-methylphthalic anhydride, (C) at least one a boron containing catalyst that is essentially free of halogen, and (D) at least one cure modifier.
- 2. The composition of claim 1, wherein the cycloaliphatic epoxy resin (A) comprises at least one cycloaliphatic group and at least two oxirane rings per molecule.
- 3. The composition of claim 2, wherein the cycloaliphatic epoxy resin (A) comprises at least one of 2-(3,4-epoxy)cyclohexyl-5, 5-spiro-(3,4-epoxy)cyclohexane-m-dioxane, 3,4-epoxycyclohexylmethyl-3,4-epoxycyclohexanecarboxylate, 3,4-epoxy-6-methylcyclohexylmethyl-3,4-epoxy-6-methylcyclohexanecarboxylate, vinyl cyclohexanedioxide, bis(3,4-epoxycyclohexylmethyl)adipate, bis(3,4-epoxy-6-methylcyclohexylmethyl)adipate, exo-exo bis(2,3-epoxycyclopentyl) ether, endo-exo bis(2,3-epoxycyclopentyl) ether, 2,2-bis(4-(2,3-epoxypropoxy)cyclohexyl)propane, 2,6-bis(2,3-epoxypropoxycyclohexyl-p-dioxane), 2,6-bis(2,3-epoxypropoxy)norbornene, the diglycidylether of linoleic acid dimer, limonene dioxide, 2,2-bis(3,4-epoxycyclohexyl)propane, dicyclopentadiene dioxide, 1,2-epoxy-6-(2,3-epoxypropoxy)hexahydro-4,7-methanoindane, p-(2,3-epoxy)cyclopentylphenyl-2,3-epoxypropylether, 1-(2,3-epoxypropoxy)phenyl-5,6-epoxyhexahydro-4,7-methanoindane, o-(2,3-epoxy)cyclopentylphenyl-2,3-epoxypropyl ether), 1,2-bis[5-(1,2-epoxy)-4,7-hexahydromethanoindanoxyl]ethane, cyclopentenylphenyl glycidyl ether, cyclohexanediol diglycidyl ether, or diglycidyl hexahydrophthalate.
- 4. The composition of claim 3, wherein the cycloaliphatic epoxy resin (A) comprises 3,4-epoxycyclohexylmethyl-3,4-epoxycyclohexanecarboxylate.
- 5. The composition of claim 1 wherein the molar ratio of curing agent (B) to cycloaliphatic epoxy resin (A) is less than 1.
- 6. The composition of claim 5 wherein the molar ratio of curing agent (B) to cycloaliphatic epoxy resin (A) is less than about 0.85.
- 7. The composition of claim 5 wherein the molar ratio of curing agent (B) to cycloaliphatic epoxy resin (A) is less than about 0.58.
- 8. The composition of claim 5 wherein the molar ratio of curing agent (B) to cycloaliphatic epoxy resin (A) is less than about 0.37.
- 9. The composition of claim 1, wherein the boron containing catalyst (C) comprises a borate.
- 10. The composition of claim 9, wherein the borate has the structure:
- 11. The composition of claim 9, wherein the borate is at least one member selected from the group consisting of triphenylborate, tributylborate, trihexylborate, and tricyclohexylborate.
- 12. The composition of claim 9, wherein the boron containing catalyst is a boroxine.
- 13. The composition of claim 12, wherein the boroxine has the structure:
- 14. The composition of claim 13, wherein the boroxine is at least one member selected from the group consisting of triphenylboroxine, trimethylboroxine, tributylboroxine, trimethoxyboroxine, and tributoxyboroxine.
- 15. The composition of claim 1, wherein the cure modifier (D) comprises at least one member selected from the group consisting of alcohols and phosphites.
- 16. The composition of claim 15, wherein the cure modifier (D) comprises at least one member selected from the group consisting of benzyl alcohol, cyclohexanemethanol, alkyl diols, cyclohexanedimethanol, ethylene glycol, propylene glycol, butanediol, pentanediol, hexanediol, heptanediol, octanediol, polyethylene glycol, glycerol, polyether polyols; trialkylphosphites, tributyl phosphite, triarylphosphites, triphenyl phosphite, benzyldiethyl phosphite, trialkylthiophosphites, and triarylthiophosphites.
- 17. The composition of claim 16, wherein the cure modifier (D) comprises 2,5-hexanediol and triphenyl phosphite.
- 18. The composition of claim 1, wherein the encapsulant further comprises at least one ancillary curing catalyst selected from the group consisting of an organometallic salt, a sulfonium salt and an iodonium salt, and present in an amount in a range of between about 0.01% by weight and about 10% by weight based on the combined weight of cycloaliphatic epoxy resin (A), anhydride curing agent (B), boron containing catalyst (C), cure modifier (D), and ancillary curing catalyst.
- 19. The composition of claim 18, wherein the ancillary curing catalyst comprises at least one member selected from the group consisting of a metal carboxylate, a metal acetylacetonate, zinc octoate, stannous octoate, triarylsulfonium hexafluorophosphate, triarylsulfonium hexafluoroantimonate, diaryliodonium hexafluoroantimonate, and diaryliodonium tetrakis(pentafluorophenyl)borate.
- 20. The composition of claim 1, further comprising at least one of thermal stabilizers, UV stabilizers, coupling agents, or refractive index modifiers.
- 21. The composition of claim 20, comprising at least one coupling agent which comprises both an alkoxysilane and an organic moiety.
- 22. The composition of claim 21, comprising at least one coupling agent of the formula (R5O)3Si—R6 wherein R5 is an alkyl group and R6 is selected from the group consisting of vinyl, 3-glycidoxypropyl, 3-mercaptopropyl, 3-acryloxypropyl, 3-methacryloxypropyl, and CnH2n+1 wherein n has the value of between 4 and 16 inclusive.
- 23. The composition of claim 22, wherein the coupling agent comprises glycidoxypropyltrimethoxysilane.
- 24. The partially cured composition of claim 1.
- 25. The cured composition of claim 1.
- 26. A curable epoxy resin composition for encapsulation of a solid state device, which comprises: (A) 3,4-epoxycyclohexylmethyl-3,4-epoxycyclohexanecarboxylate, (B) hexahydro-4-methylphthalic anhydride, (C) trimethoxyboroxine, and (D) 2,5-hexanediol and triphenylphosphite, wherein component (A) is present at a level of greater than about 60% by weight based on the combined weight of components (A), (B), (C), and (D); component (C) is present at a level in a range of between about 1% by weight and about 6% by weight based on the combined weight of components (A), (B), (C), and (D); component (D) is present at a level in a range of between about 1% by weight and about 6% by weight based on the combined weight of components (A), (B), (C), and (D); and the molar ratio of component (B) to component (A) is less than about 0.37.
- 27. The composition of claim 26, wherein the encapsulant further comprises at least one of thermal stabilizers, UV stabilizers, coupling agents, or refractive index modifiers.
- 28. The composition of claim 27, wherein the coupling agent comprises glycidoxypropyltrimethoxysilane.
- 29. The partially cured composition of claim 26.
- 30. The cured composition of claim 26.
- 31. A packaged solid state device comprising: (a) a package; (b) a chip; and (c) an encapsulant comprising: (A) at least one cycloaliphatic epoxy resin, (B) a curing agent comprising hexahydro-4-methylphthalic anhydride, (C) at least one a boron containing catalyst that is essentially free of halogen, and (D) at least one cure modifier.
- 32. The packaged solid state device of claim 31, wherein the cycloaliphatic epoxy resin (A) comprises at least one cycloaliphatic group and at least two oxirane rings per molecule.
- 33. The packaged solid state device of claim 32, wherein the cycloaliphatic epoxy resin (A) comprises at least one of 2-(3,4-epoxy)cyclohexyl-5,5-spiro-(3,4-epoxy)cyclohexane-m-dioxane, 3,4-epoxycyclohexylmethyl-3,4-epoxycyclohexanecarboxylate, 3,4-epoxy-6-methylcyclohexylmethyl-3,4-epoxy-6-methylcyclohexanecarboxylate, vinyl cyclohexanedioxide, bis(3,4-epoxycyclohexylmethyl)adipate, bis(3,4-epoxy-6-methylcyclohexylmethyl)adipate, exo-exo bis(2,3-epoxycyclopentyl) ether, endo-exo bis(2,3-epoxycyclopentyl) ether, 2,2-bis(4-(2,3-epoxypropoxy)cyclohexyl)propane, 2,6-bis(2,3-epoxypropoxycyclohexyl-p-dioxane), 2,6-bis(2,3-epoxypropoxy)norbomene, the diglycidylether of linoleic acid dimer, limonene dioxide, 2,2-bis(3,4-epoxycyclohexyl)propane, dicyclopentadiene dioxide, 1,2-epoxy-6-(2,3-epoxypropoxy)hexahydro-4,7-methanoindane, p-(2,3-epoxy)cyclopentylphenyl-2,3-epoxypropylether, 1-(2,3-epoxypropoxy)phenyl-5,6-epoxyhexahydro-4,7-methanoindane, o-(2,3-epoxy)cyclopentylphenyl-2,3-epoxypropyl ether), 1,2-bis[5-(1,2-epoxy)-4,7-hexahydromethanoindanoxyl]ethane, cyclopentenylphenyl glycidyl ether, cyclohexanediol diglycidyl ether, or diglycidyl hexahydrophthalate.
- 34. The packaged solid state device of claim 33, wherein the cycloaliphatic epoxy resin (A) comprises 3,4-epoxycyclohexylmethyl-3,4-epoxycyclohexanecarboxylate.
- 35. The packaged solid state device of claim 31 wherein the molar ratio of curing agent (B) to cycloaliphatic epoxy resin (A) is less than 1.
- 36. The packaged solid state device of claim 35 wherein the molar ratio of curing agent (B) to cycloaliphatic epoxy resin (A) is less than about 0.85.
- 37. The packaged solid state device of claim 35 wherein the molar ratio of curing agent (B) to cycloaliphatic epoxy resin (A) is less than about 0.58.
- 38. The packaged solid state device of claim 35 wherein the molar ratio of curing agent (B) to cycloaliphatic epoxy resin (A) is less than about 0.37.
- 39. The packaged solid state device of claim 31, wherein the boron containing catalyst (C) comprises a borate.
- 40. The packaged solid state device of claim 39, wherein the borate has the structure:
- 41. The packaged solid state device of claim 39, wherein the borate is at least one member selected from the group consisting of triphenylborate, tributylborate, trihexylborate, and tricyclohexylborate.
- 42. The packaged solid state device of claim 39, wherein the boron containing catalyst is a boroxine.
- 43. The packaged solid state device of claim 42, wherein the boroxine has the structure:
- 44. The packaged solid state device of claim 43, wherein the boroxine is at least one member selected from the group consisting of triphenylboroxine, trimethylboroxine, tributylboroxine, trimethoxyboroxine, and tributoxyboroxine.
- 45. The packaged solid state device of claim 31, wherein the cure modifier (D) comprises at least one member selected from the group consisting of alcohols and phosphites.
- 46. The packaged solid state device of claim 45, wherein the cure modifier (D) comprises at least one member selected from the group consisting of benzyl alcohol, cyclohexanemethanol, alkyl diols, cyclohexanedimethanol, ethylene glycol, propylene glycol, butanediol, pentanediol, hexanediol, heptanediol, octanediol, polyethylene glycol, glycerol, polyether polyols; trialkylphosphites, tributyl phosphite, triarylphosphites, triphenyl phosphite, benzyldiethyl phosphite, trialkylthiophosphites, and triarylthiophosphites.
- 47. The packaged solid state device of claim 46, wherein the cure modifier (D) comprises 2,5-hexanediol and triphenyl phosphite.
- 48. The packaged solid state device of claim 31, wherein the encapsulant further comprises at least one ancillary curing catalyst selected from the group consisting of an organometallic salt, a sulfonium salt and an iodonium salt, and present in an amount in a range of between about 0.01% by weight and about 10% by weight based on the combined weight of cycloaliphatic epoxy resin (A), anhydride curing agent (B), boron containing catalyst (C), cure modifier (D), and ancillary curing catalyst.
- 49. The packaged solid state device of claim 48, wherein the ancillary curing catalyst comprises at least one member selected from the group consisting of a metal carboxylate, a metal acetylacetonate, zinc octoate, stannous octoate, triarylsulfonium hexafluorophosphate, triarylsulfonium hexafluoroantimonate, diaryliodonium hexafluoroantimonate, and diaryliodonium tetrakis(pentafluorophenyl)borate.
- 50. The packaged solid state device of claim 31, further comprising at least one of thermal stabilizers, UV stabilizers, coupling agents, or refractive index modifiers.
- 51. The packaged solid state device of claim 50, comprising at least one coupling agent which comprises both an alkoxysilane and an organic moiety.
- 52. The packaged solid state device of claim 51, comprising at least one coupling agent of the formula (R5O)3Si—R6 wherein R5 is an alkyl group and R is selected from the group consisting of vinyl, 3-glycidoxypropyl, 3-mercaptopropyl, 3-acryloxypropyl, 3-methacryloxypropyl, and CnH2n+1 wherein n has the value of between 4 and 16 inclusive.
- 53. The packaged solid state device of claim 52, wherein the coupling agent comprises glycidoxypropyltrimethoxysilane.
- 54. The packaged solid state device of claim 31 in which the encapsulant is partially cured.
- 55. The packaged solid state device of claim 31 in which the encapsulant is cured.
- 56. A packaged solid state device, which comprises (a) a package; (b) a chip; and (c) an encapsulant comprising: (A) 3,4-epoxycyclohexylmethyl-3,4-epoxycyclohexanecarboxylate, (B) hexahydro-4-methylphthalic anhydride, (C) trimethoxyboroxine, and (D) 2,5-hexanediol and triphenylphosphite, wherein component (A) is present at a level of greater than about 60% by weight based on the combined weight of components (A), (B), (C), and (D); component (C) is present at a level in a range of between about 1% by weight and about 6% by weight based on the combined weight of components (A), (B), (C), and (D); component (D) is present at a level in a range of between about 1% by weight and about 6% by weight based on the combined weight of components (A), (B), (C), and (D); and the molar ratio of component (B) to component (A) is less than about 0.37.
- 57. The packaged solid state device of claim 56, wherein the encapsulant further comprises at least one of thermal stabilizers, UV stabilizers, coupling agents, or refractive index modifiers.
- 58. The packaged solid state device of claim 57, wherein the coupling agent comprises glycidoxypropyltrimethoxysilane.
- 59. The packaged solid state device of claim 56 in which the encapsulant is partially cured.
- 60. The packaged solid state device of claim 56 in which the encapsulant is cured.
- 61. A LED device comprising: (a) a package; (b) a LED chip; and (c) an encapsulant comprising: (A) 3,4-epoxycyclohexylmethyl-3,4-epoxycyclohexanecarboxylate, (B) hexahydro-4-methylphthalic anhydride, (C) trimethoxyboroxine, and (D) 2,5-hexanediol and triphenylphosphite, wherein component (A) is present at a level of greater than about 60% by weight based on the combined weight of components (A), (B), (C), and (D); component (C) is present at a level in a range of between about 1% by weight and about 6% by weight based on the combined weight of components (A), (B), (C), and (D); component (D) is present at a level in a range of between about 1% by weight and about 6% by weight based on the combined weight of components (A), (B), (C), and (D); and the molar ratio of component (B) to component (A) is less than about 0.37.
- 62. The LED device of claim 61, wherein the encapsulant further comprises at least one of thermal stabilizers, UV stabilizers, coupling agents, or refractive index modifiers.
- 63. The LED device of claim 62, wherein the coupling agent comprises glycidoxypropyltrimethoxysilane.
- 64. The LED device of claim 61 in which the encapsulant is partially cured.
- 65. The LED device of claim 61 in which the encapsulant is cured.
- 66. A method of encapsulating a solid state device comprising: placing a solid state device into a package; and providing an encapsulant comprising: (A) at least one cycloaliphatic epoxy resin, (B) a curing agent comprising hexahydro-4-methylphthalic anhydride, (C) at least one a boron containing catalyst that is essentially free of halogen, and (D) at least one cure modifier.
- 67. The method of claim 66, wherein the solid state device is a semiconductor device.
- 68. The method of claim 66, wherein the solid state device is an opto-electronic device.
- 69. The method of claim 68, wherein the opto-electronic device is semiconductor device comprising: a LED, CCD, LSI, photodiode, phototransistor, or opto-electronic coupler.
- 70. The method of claim 66, wherein the package comprises a shell or lens.
- 71. The method of claim 66, wherein the cycloaliphatic epoxy resin (A) comprises at least one cycloaliphatic group and at least two oxirane rings per molecule.
- 72. The method of claim 71, wherein the cycloaliphatic epoxy resin (A) comprises at least one of 2-(3,4-epoxy)cyclohexyl-5, 5-spiro-(3,4-epoxy)cyclohexane-m-dioxane, 3,4-epoxycyclohexylmethyl-3,4-epoxycyclohexanecarboxylate, 3,4-epoxy-6-methylcyclohexylmethyl-3,4-epoxy-6-methylcyclohexanecarboxylate, vinyl cyclohexanedioxide, bis(3,4-epoxycyclohexylmethyl)adipate, bis(3,4-epoxy-6-methylcyclohexylmethyl)adipate, exo-exo bis(2,3-epoxycyclopentyl) ether, endo-exo bis(2,3-epoxycyclopentyl) ether, 2,2-bis(4-(2,3-epoxypropoxy)cyclohexyl)propane, 2,6-bis(2,3-epoxypropoxycyclohexyl-p-dioxane), 2,6-bis(2,3-epoxypropoxy)norbornene, the diglycidylether of linoleic acid dimer, limonene dioxide, 2,2-bis(3,4-epoxycyclohexyl)propane, dicyclopentadiene dioxide, 1,2-epoxy-6-(2,3-epoxypropoxy)hexahydro-4,7-methanoindane, p-(2,3-epoxy)cyclopentylphenyl-2,3-epoxypropylether, 1-(2,3-epoxypropoxy)phenyl-5,6-epoxyhexahydro-4,7-methanoindane, o-(2,3-epoxy)cyclopentylphenyl-2,3-epoxypropyl ether), 1,2-bis[5-(1,2-epoxy)-4,7-hexahydromethanoindanoxyl]ethane, cyclopentenylphenyl glycidyl ether, cyclohexanediol diglycidyl ether, or diglycidyl hexahydrophthalate.
- 73. The method of claim 72, wherein the cycloaliphatic epoxy resin (A) comprises 3,4-epoxycyclohexylmethyl-3,4-epoxycyclohexanecarboxylate.
- 74. The method of claim 66 wherein the molar ratio of anhydride curing agent (B) to cycloaliphatic epoxy resin (A) is less than 1.
- 75. The method of claim 74 wherein the molar ratio of anhydride curing agent (B) to cycloaliphatic epoxy resin (A) is less than about 0.85.
- 76. The method of claim 74 wherein the molar ratio of anhydride curing agent (B) to cycloaliphatic epoxy resin (A) is less than about 0.58.
- 77. The method of claim 74 wherein the molar ratio of anhydride curing agent (B) to cycloaliphatic epoxy resin (A) is less than about 0.37.
- 78. The method of claim 66, wherein the boron containing catalyst (C) comprises a borate.
- 79. The method of claim 78, wherein the borate has the structure:
- 80. The method of claim 79, wherein the borate is at least one member selected from the group consisting of triphenylborate, tributylborate, trihexylborate, and tricyclohexylborate.
- 81. The method of claim 66, wherein the boron containing catalyst is a boroxine.
- 82. The method of claim 81, wherein the boroxine has the structure:
- 83. The method of claim 82, wherein the boroxine is at least one member selected from the group consisting of triphenylboroxine, trimethylboroxine, tributylboroxine, trimethoxyboroxine, and tributoxyboroxine.
- 84. The method of claim 66, wherein the cure modifier (D) comprises at least one member selected from the group consisting of alcohols and phosphites.
- 85. The method of claim 84, wherein the cure modifier (D) comprises at least one member selected from the group consisting of benzyl alcohol, cyclohexanemethanol, alkyl diols, cyclohexanedimethanol, ethylene glycol, propylene glycol, butanediol, pentanediol, hexanediol, heptanediol, octanediol, polyethylene glycol, glycerol, polyether polyols; trialkylphosphites, tributyl phosphite, triarylphosphites, triphenyl phosphite, benzyldiethyl phosphite, trialkylthiophosphites, and triarylthiophosphites.
- 86. The method of claim 85, wherein the cure modifier (D) comprises 2,5-hexanediol and triphenyl phosphite.
- 87. The method of claim 66, wherein the encapsulant further comprises at least one ancillary curing catalyst selected from the group consisting of an organometallic salt, a sulfonium salt and an iodonium salt, and present in an amount in a range of between about 0.01% by weight and about 10% by weight based on the combined weight of cycloaliphatic epoxy resin (A), anhydride curing agent (B), boron containing catalyst (C), cure modifier (D), and ancillary curing catalyst (E).
- 88. The method of claim 87, wherein the ancillary curing catalyst (E) is at least one member selected from the group consisting of an organometallic salt, a sulfonium salt and an iodonium salt.
- 89. The method of claim 88, wherein the ancillary curing catalyst (E) comprises at least one member selected from the group consisting of a metal carboxylate, a metal acetylacetonate, zinc octoate, stannous octoate, triarylsulfonium hexafluorophosphate, triarylsulfonium hexafluoroantimonate, diaryliodonium hexafluoroantimonate, and diaryliodonium tetrakis(pentafluorophenyl)borate.
- 90. The method of claim 66, wherein the encapsulant further comprises at least one of thermal stabilizers, UV stabilizers, coupling agents, or refractive index modifiers.
- 91. The method of claim 90, wherein the encapsulant comprises at least one coupling agent which comprises both an alkoxysilane and an organic moiety.
- 92. The method of claim 91, wherein the encapsulant comprises at least one coupling agent of the formula (R5O)3Si—R6 wherein R5 is an alkyl group and R6 is selected from the group consisting of vinyl, 3-glycidoxypropyl, 3-mercaptopropyl, 3-acryloxypropyl, 3-methacryloxypropyl, and CnH2n+1 wherein n has the value of between 4 and 16 inclusive.
- 93. The method of claim 92, wherein the coupling agent comprises glycidoxypropyltrimethoxysilane.
- 94. The method of claim 66 in which the encapsulant is partially cured.
- 95. The method of claim 66 in which the encapsulant is cured.
- 96. A method of encapsulating a LED device comprising: placing a LED device into a package; and providing an encapsulant comprising: (A) 3,4-epoxycyclohexylmethyl-3,4-epoxycyclohexanecarboxylate, (B) hexahydro-4-methylphthalic anhydride, (C) trimethoxyboroxine, and (D) 2,5-hexanediol and triphenylphosphite, wherein component (A) is present at a level of greater than about 60% by weight based on the combined weight of components (A), (B), (C), and (D); component (C) is present at a level in a range of between about 1% by weight and about 6% by weight based on the combined weight of components (A), (B), (C), and (D); component (D) is present at a level in a range of between about 1% by weight and about 6% by weight based on the combined weight of components (A), (B), (C), and (D); and the molar ratio of component (B) to component (A) is less than about 0.37.
- 97. The method of claim 96, wherein the encapsulant further comprises at least one of thermal stabilizers, UV stabilizers, coupling agents, or refractive index modifiers.
- 98. The method of claim 97, wherein the encapsulant comprises glycidoxypropyltrimethoxysilane.
- 99. The method of claim 96 in which the encapsulant is partially cured.
- 100. The method of claim 96 in which the encapsulant is cured.
STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH & DEVELOPMENT
[0001] This invention was first conceived or reduced to practice in the performance of work under contract 70NANB8H4022 with the United States National Institute of Standards and Technology (NIST). The United States of America may have certain rights to this invention.